These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 8041156

  • 1. Nitric oxide inhibition in the treatment of the sepsis syndrome is detrimental to tissue oxygenation.
    Statman R, Cheng W, Cunningham JN, Henderson JL, Damiani P, Siconolfi A, Rogers D, Horovitz JH.
    J Surg Res; 1994 Jul; 57(1):93-8. PubMed ID: 8041156
    [Abstract] [Full Text] [Related]

  • 2. In vivo quantification of endotoxin-induced nitric oxide production in pigs from Na15NO3-infusion.
    Santak B, Radermacher P, Iber T, Adler J, Wachter U, Vassilev D, Georgieff M, Vogt J.
    Br J Pharmacol; 1997 Dec; 122(8):1605-10. PubMed ID: 9422804
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. NG-methyl-L-arginine, an inhibitor of nitric oxide formation, acts synergistically with dobutamine to improve cardiovascular performance in endotoxemic dogs.
    Kilbourn RG, Cromeens DM, Chelly FD, Griffith OW.
    Crit Care Med; 1994 Nov; 22(11):1835-40. PubMed ID: 7956289
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Hemodynamic effects of sub-chronic NO synthase inhibition in conscious dogs: role of EDRF/NO in muscular exertion].
    Puybasset L, Béa ML, Simon L, Ghaleh B, Giudicelli JF, Berdeaux A.
    Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1217-21. PubMed ID: 8572877
    [Abstract] [Full Text] [Related]

  • 8. Effects of a nitric oxide synthase inhibitor in humans with septic shock.
    Petros A, Lamb G, Leone A, Moncada S, Bennett D, Vallance P.
    Cardiovasc Res; 1994 Jan; 28(1):34-9. PubMed ID: 7509259
    [Abstract] [Full Text] [Related]

  • 9. Detrimental hemodynamic effects of nitric oxide synthase inhibition in septic shock.
    Robertson FM, Offner PJ, Ciceri DP, Becker WK, Pruitt BA.
    Arch Surg; 1994 Feb; 129(2):149-55; discussion 155-6. PubMed ID: 7508219
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Intrarenal haemodynamics and renal dysfunction in endotoxaemia: effects of nitric oxide synthase inhibition.
    Millar CG, Thiemermann C.
    Br J Pharmacol; 1997 Aug; 121(8):1824-30. PubMed ID: 9283724
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Role for nitric oxide in the hyperpermeability and hemodynamic changes induced by intravenous VEGF.
    Tilton RG, Chang KC, LeJeune WS, Stephan CC, Brock TA, Williamson JR.
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):689-96. PubMed ID: 10067972
    [Abstract] [Full Text] [Related]

  • 17. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M, Plank C, Meissner U, Eberle KP, Weyand M, Cesnjevar R, Dötsch J, Rascher W.
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [Abstract] [Full Text] [Related]

  • 18. Nitric oxide and the haemodynamic profile of endotoxin shock in the conscious mouse.
    Rees DD, Monkhouse JE, Cambridge D, Moncada S.
    Br J Pharmacol; 1998 Jun; 124(3):540-6. PubMed ID: 9647479
    [Abstract] [Full Text] [Related]

  • 19. Effects of nitric oxide synthase inhibition combined with nitric oxide inhalation in a porcine model of endotoxin shock.
    Klemm P, Thiemermann C, Winklmaier G, Martorana PA, Henning R.
    Br J Pharmacol; 1995 Jan; 114(2):363-8. PubMed ID: 7533615
    [Abstract] [Full Text] [Related]

  • 20. Prophylactic high-dose N(omega)-monomethyl-L-arginine prevents the late cardiac dysfunction associated with lethal tumor necrosis factor-alpha challenge in dogs.
    Sevransky J, Vandivier RW, Gerstenberger E, Correa R, Ferantz V, Banks SM, Danner RL, Eichacker PQ, Natanson C.
    Shock; 2005 Mar; 23(3):281-8. PubMed ID: 15718929
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.